NCT01791686View on ClinicalTrials.gov

Clinical Trial of CDX-1135 in Pediatric and Adult Patients With Dense Deposit Disease

PHASE1TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Dense Deposit DiseaseMembranoproliferative Glomerulonephritis Type IIC3 Glomerulonephritis
Interventions
DRUG

CDX-1135

Trial Locations (1)

52242

University of Iowa Hospitals & Clinics, Iowa City

Sponsors
All Listed Sponsors
lead

Celldex Therapeutics

INDUSTRY

NCT01791686 - Clinical Trial of CDX-1135 in Pediatric and Adult Patients With Dense Deposit Disease | Biotech Hunter | Biotech Hunter